5HGG image
Entry Detail
PDB ID:
5HGG
Title:
Crystal structure of uPA in complex with a camelid-derived antibody fragment
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2016-01-08
Release Date:
2016-06-01
Method Details:
Experimental Method:
Resolution:
1.97 Å
R-Value Free:
0.19
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Urokinase-type plasminogen activator
Mutations:C122A, N145Q
Chain IDs:A, B
Chain Length:246
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Camelid Derived Antibody Fragment, Nb4
Chain IDs:C (auth: S), D (auth: T)
Chain Length:128
Number of Molecules:2
Biological Source:Vicugna pacos
Primary Citation
A Camelid-derived Antibody Fragment Targeting the Active Site of a Serine Protease Balances between Inhibitor and Substrate Behavior
J.Biol.Chem. 291 15156 15168 (2016)
PMID: 27226628 DOI: 10.1074/jbc.M116.732503

Abstact

A peptide segment that binds the active site of a serine protease in a substrate-like manner may behave like an inhibitor or a substrate. However, there is sparse information on which factors determine the behavior a particular peptide segment will exhibit. Here, we describe the first x-ray crystal structure of a nanobody in complex with a serine protease. The nanobody displays a new type of interaction between an antibody and a serine protease as it inserts its complementary determining region-H3 loop into the active site of the protease in a substrate-like manner. The unique binding mechanism causes the nanobody to behave as a strong inhibitor as well as a poor substrate. Intriguingly, its substrate behavior is incomplete, as 30-40% of the nanobody remained intact and inhibitory after prolonged incubation with the protease. Biochemical analysis reveals that an intra-loop interaction network within the complementary determining region-H3 of the nanobody balances its inhibitor versus substrate behavior. Collectively, our results unveil molecular factors, which may be a general mechanism to determine the substrate versus inhibitor behavior of other protease inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures